Table 3.
Prevalence of metabolic syndrome according to four definitions and its components in pregnant women
| Components of MetS | NCEPT–ATP III [5] N = 675 |
JIS MetS Criteria [6] N = 675 |
NCEPT–ATP III Bartha [10] modification N = 675 | NHLBI/AHA Chatzi [8, 9] modification N = 675 |
||||
|---|---|---|---|---|---|---|---|---|
| Cut points | N (%) | Cut points | N (%) | Cut points | N (%) | Cut points | N (%) | |
| Fasting glycemia mean | ≥110 mg/dl | 70 (10.4) | ≥100 mg/dl | 124 (18.4) | ≥105 mg/dl | 90 (13.3) | ≥100 mg/dl | 124 (18.4) |
| Obesity | ||||||||
| BMI | – | – | >30 kg/m2 | 75 (11.1) | >30 kg/m2 | 75 (11.1) | ||
| Waist circumference | >88 cm | 497 (73.6) | ≥80 cm | 657 (97.3) | _ | – | – | |
| Hypertriglyceridemia | ≥150 mg/dl | 293 (43.4) | ≥150 mg/dl | 293 (43.4) | ≥270 mg/dl | 15 (2.2) | ≥150 mg/dl | 293 (43.4) |
| Decreased HDL-C | <50 mg/dl | 53 (7.8) | <50 mg/dl | 53 (7.9) | <40 mg/dl | 17 (2.5) | <50 mg/dl | 53 (7.9) |
| Hypertension | ≥130/85 mm/Hg | 370 (54.8) | ≥130/85 mm/Hg | 370 (54.8) | ≥ 130/85 mm/Hg | 370 (54.8) | ≥ 130/85 mm/Hg | 370 (54.8) |
| MetS prevalence | 197 (29.2) | 247 (36.6) | 12 (1.8) | 85 (12.6) | ||||
* Differences of the test proporcções—p < 0.0001 (a, b, c and d)